{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:19:29Z","timestamp":1788527969508,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2025JJ60730"],"award-info":[{"award-number":["2025JJ60730"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbrc.2026.154407","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T23:27:12Z","timestamp":1786145232000},"page":"154407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identification of molecular subtypes in clear cell renal cell carcinoma based on chromatin regulators and tumor immune microenvironment profiling"],"prefix":"10.1016","volume":"833","author":[{"given":"Lei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deshen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbrc.2026.154407_bib2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eururo.2014.04.029","article-title":"Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity","volume":"67","author":"Shuch","year":"2015","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154407_bib3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/hmg\/ddad181","article-title":"Characterizing and predicting ccRCC-causing missense mutations in Von Hippel-Lindau disease","volume":"33","author":"Serghini","year":"2024","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"10.1016\/j.bbrc.2026.154407_bib4","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/HJH.0000000000001286","article-title":"Blood pressure and kidney cancer risk: meta-analysis of prospective studies","volume":"35","author":"Hidayat","year":"2017","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154407_bib5","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2015.06.042","article-title":"The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks","volume":"70","author":"Cumberbatch","year":"2016","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154407_bib6","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.juro.2013.04.130","article-title":"Risk factors for renal cell carcinoma in the VITAL study","volume":"190","author":"Macleod","year":"2013","journal-title":"J. Urol."},{"issue":"7","key":"10.1016\/j.bbrc.2026.154407_bib7","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1054\/bjoc.2001.2040","article-title":"Obesity and renal cell cancer--a quantitative review","volume":"85","author":"Bergstrom","year":"2001","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.bbrc.2026.154407_bib8","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.3390\/cancers3044010","article-title":"Role of radiation therapy in the management of renal cell cancer","volume":"3","author":"Blanco","year":"2011","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2026.154407_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.bbrc.2026.154407_bib10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.critrevonc.2015.08.007","article-title":"Cytotoxic chemotherapy in the treatment of advanced renal cell carcinoma in the era of targeted therapy","volume":"96","author":"Diamond","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154407_bib11","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1111\/cas.14192","article-title":"Mitochondrial E3 ubiquitin ligase 1 promotes autophagy flux to suppress the development of clear cell renal cell carcinomas","volume":"110","author":"Yuan","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2026.154407_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bav067","article-title":"EpiFactors: a comprehensive database of human epigenetic factors and complexes","author":"Medvedeva","year":"2015","journal-title":"Database (Oxford)"},{"issue":"11","key":"10.1016\/j.bbrc.2026.154407_bib13","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nrg3554","article-title":"Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer","volume":"14","author":"Plass","year":"2013","journal-title":"Nat. Rev. Genet."},{"issue":"9","key":"10.1016\/j.bbrc.2026.154407_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2013-14-9-r106","article-title":"The mutational landscape of chromatin regulatory factors across 4,623 tumor samples","volume":"14","author":"Gonzalez-Perez","year":"2013","journal-title":"Genome Biol."},{"issue":"D1","key":"10.1016\/j.bbrc.2026.154407_bib15","doi-asserted-by":"crossref","first-page":"D918","DOI":"10.1093\/nar\/gkx877","article-title":"CR2Cancer: a database for chromatin regulators in human cancer","volume":"46","author":"Ru","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.154407_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.biochem.77.062706.153223","article-title":"The biology of chromatin remodeling complexes","volume":"78","author":"Clapier","year":"2009","journal-title":"Annu. Rev. Biochem."},{"issue":"9","key":"10.1016\/j.bbrc.2026.154407_bib17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41580-018-0029-7","article-title":"Regulation of chromatin and gene expression by metabolic enzymes and metabolites","volume":"19","author":"Li","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154407_bib18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154407_bib19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.4161\/epi.28324","article-title":"The de novo DNA methyltransferase DNMT3A in development and cancer","volume":"9","author":"Chen","year":"2014","journal-title":"Epigenetics"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154407_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010016","article-title":"Prognostic and predictive value of PBRM1 in clear cell renal cell carcinoma","volume":"12","author":"Carril-Ajuria","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.bbrc.2026.154407_bib21","doi-asserted-by":"crossref","first-page":"340 e349","DOI":"10.1016\/j.urolonc.2015.01.010","article-title":"Decreased PBRM1 expression predicts unfavorable prognosis in patients with clear cell renal cell carcinoma","volume":"33","author":"Nam","year":"2015","journal-title":"Urol. Oncol."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154407_bib22","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1002\/ijc.27822","article-title":"Loss of PBRM1 expression is associated with renal cell carcinoma progression","volume":"132","author":"Pawlowski","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154407_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41419-020-2266-x","article-title":"SETD2 mutation in renal clear cell carcinoma suppress autophagy via regulation of ATG12","volume":"11","author":"Gonzalez-Rodriguez","year":"2020","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.bbrc.2026.154407_bib24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.18632\/oncotarget.26567","article-title":"SETD2 loss sensitizes cells to PI3Kbeta and AKT inhibition","volume":"10","author":"Terzo","year":"2019","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.bbrc.2026.154407_bib25","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/s41591-020-0839-y","article-title":"Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma","volume":"26","author":"Braun","year":"2020","journal-title":"Nat. Med."},{"issue":"19","key":"10.1016\/j.bbrc.2026.154407_bib26","doi-asserted-by":"crossref","first-page":"10019","DOI":"10.1093\/nar\/gky679","article-title":"FACER: comprehensive molecular and functional characterization of epigenetic chromatin regulators","volume":"46","author":"Lu","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154407_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2193528","article-title":"Update on combined immunotherapy for the treatment of advanced renal cell carcinoma","volume":"19","author":"Gebrael","year":"2023","journal-title":"Hum. Vaccines Immunother."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154407_bib28","article-title":"Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas","volume":"4","author":"Lu","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"7","key":"10.1016\/j.bbrc.2026.154407_bib29","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1158\/1078-0432.CCR-22-2133","article-title":"An enhancer demethylator phenotype converged to immune dysfunction and resistance to immune checkpoint inhibitors in clear-cell renal cell carcinomas","volume":"29","author":"Lu","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.bbrc.2026.154407_bib33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41581-020-0301-x","article-title":"Genomic profiling in renal cell carcinoma","volume":"16","author":"Dizman","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154407_bib34","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.7150\/jca.38391","article-title":"Histone methyltransferase SETD2: a potential tumor suppressor in solid cancers","volume":"11","author":"Chen","year":"2020","journal-title":"J. Cancer"},{"issue":"3","key":"10.1016\/j.bbrc.2026.154407_bib35","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1074\/mcp.RA118.000957","article-title":"Integrated genomic and proteomic analyses reveal novel mechanisms of the methyltransferase SETD2 in renal cell carcinoma development","volume":"18","author":"Li","year":"2019","journal-title":"Mol. Cell. Proteomics"},{"issue":"3","key":"10.1016\/j.bbrc.2026.154407_bib37","first-page":"209","article-title":"SATB1 is down-regulated in clear cell renal cell carcinoma and correlates with miR-21-5p overexpression and poor prognosis","volume":"13","author":"Kowalczyk","year":"2016","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.bbrc.2026.154407_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111040","article-title":"MBIP promotes ESCC metastasis by activating MAPK pathway","volume":"115","author":"Ma","year":"2024","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154407_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.167011","article-title":"USP46 enhances tamoxifen resistance in breast cancer cells by stabilizing PTBP1 to facilitate glycolysis","volume":"1870","author":"Gao","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154407_bib41","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.11902","article-title":"Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2","volume":"23","author":"Xu","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154407_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0594-85","article-title":"Mutations of the VHL tumour suppressor gene in renal carcinoma","volume":"7","author":"Gnarra","year":"1994","journal-title":"Nat. Genet."},{"issue":"9605","key":"10.1016\/j.bbrc.2026.154407_bib43","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/S0140-6736(07)61904-7","article-title":"Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial","volume":"370","author":"Escudier","year":"2007","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.bbrc.2026.154407_bib44","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa066838","article-title":"Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma","volume":"356","author":"Hudes","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154407_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10112840","article-title":"Contemporary drug therapy for renal cell Carcinoma- evidence accumulation and histological implications in treatment strategy","volume":"10","author":"Yamana","year":"2022","journal-title":"Biomedicines"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2601171X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2601171X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:46:13Z","timestamp":1788525973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2601171X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"alternative-id":["S0006291X2601171X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154407","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of molecular subtypes in clear cell renal cell carcinoma based on chromatin regulators and tumor immune microenvironment profiling","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154407","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154407"}}